GB-0895
GB-0895-301 (SOLAIRIA-1)
Phase 3 small_molecule active
Quick answer
GB-0895 for Severe Asthma is a Phase 3 program (small_molecule) at Generate Biomedicines with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Generate Biomedicines
- Indication
- Severe Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active